| JXSB2200130 | BI655130注射液 | spesolimab | Injection | Biological Products(1) | Supplementary Application | 2022-10-18 | | Boehringer Ingelheim International GmbH | | | view |
| JXSL2101098 | BI655130注射液 | spesolimab | Injection | Biological Products(1) | Import Drug Application | 2021-08-23 | | | | | view |
| JXSB2101037 | BI655130注射液 | spesolimab | Injection | Biological Products(1) | Supplementary Application | 2021-07-24 | | Boehringer Ingelheim International GmbH | | | view |
| JXSL2101006 | BI655130注射液 | spesolimab | Injection | Biological Products(1) | Import Drug Application | 2021-04-10 | | | | | view |
| JXSB2000053 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXSB2000052 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-12-21 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-19 | view |
| JXSB2000010 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-08-27 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-08-26 | view |
| JYSB2000191 | BI655130注射液 | spesolimab | Injection | Biological Products | Supplementary Application | 2020-05-23 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-05-22 | view |
| JXSL2000006 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JXSL2000007 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JXSL2000011 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JXSL2000013 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JXSL2000012 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-02-14 | view |
| JXSL1900124 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2019-12-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2019-12-04 | view |
| JXSL1900125 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2019-12-05 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2019-12-04 | view |
| JXSL1900079 | BI655130注射液 | spesolimab | Injection | Biological Products | Import Drug Application | 2019-09-11 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2019-09-10 | view |
